Abedi, Farshad MD, DMedSc; Wickremasinghe, Sanjeewa FRCOphth, FRANZCO; Islam, Amirul F. M. PhD; Inglis, Kellie M. BHSc; Guymer, Robyn H. PhD, FRANZCO
Center for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Victoria, Australia.
Reprint requests: Farshad Abedi, MD, DMedSc, 3/5-13 Huchinson Street, Surry Hills 2010, Australia; e-mail: [email protected]
Supported by the National Health and Medical Research Council (NHMRC) project grants 590205 and 1008979, an NHMRC Clinical Research Excellence grant 529923, NHMRC practitioner fellowship (RHG), and NHMRC Fight Retinal Blindness (FRB) grant 632663. The Centre for Eye Research Australia (CERA) receives Operational Infrastructure Support from the Victorian Government. The sponsor or funding organizations had no role in the design or conduct of this research.
This work was partly presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Seattle, WA, May, 2013.
Professor R. H. Guymer is a member of the advisory boards of Novartis (Australia) and Bayer (Australia). Dr. S. Wickremasinghe has received speaker fees from Novartis (Australia). Dr. F. Abedi, Dr. A. F. M. Islam, and Ms. K. M. Inglis had no proprietary interest.
